William Blair analyst Myles Minter reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares opened ...

Arizona State Retirement System raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 8.8% in the ...

Jones Financial Companies Lllp boosted its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...

Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...

The use of glycine in a neutral solution enhances lithium extraction from spent batteries, offering a sustainable alternative ...

Vis spectroscopy to investigate the kinetically controlled growth of Co(OH)₂. They discovered that Co polyhedra with ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical applications.